Ethambutol/isoniazid
| Combination of | |
|---|---|
| Ethambutol | Anti-tuberculosis medication |
| Isoniazid | Anti-tuberculosis medication |
| Clinical data | |
| Pregnancy category |
|
| ATC code | |
Ethambutol/isoniazid is a medication used to treat tuberculosis. It is a fixed dose combination of ethambutol and isoniazid. It is used along with other antituberculosis medication. It is taken by mouth.[1]
Side effects are those of the underlying medications.[1] More common side effects include poor coordination, numbness, and liver problems. Liver problems may be severe and are more likely in people over the age of 50.[2] Use is not recommended in children.[1] It is unclear if use in pregnancy is safe for the baby.[2]
It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.[3] The wholesale cost in the developing world is about 1.47 to 1.99 USD a month.[4] The combination product is not available in Canada or the United States.[2]
References
- 1 2 3 WHO Model Formulary 2008 (PDF). World Health Organization. 2009. p. 140. ISBN 9789241547659. Retrieved 8 December 2016.
- 1 2 3 "Ethambutol and Isoniazid Drug Information, Professional". www.drugs.com. November 1998. Retrieved 18 December 2016.
- ↑ "WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Retrieved 8 December 2016.
- ↑ "Ethambutol + Isoniazid". International Drug Price Indicator Guide. Retrieved 8 December 2016.